ArticleTherapeutic advances in medical oncology2018

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib.

Bruno Vincenzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.